🔎 Trials Near Me

Akèy › Hyperlipoprotéinémie de type II

Etid klinik pou Hyperlipoprotéinémie de type II ap rekrite nan Etazini

10 etid pou Hyperlipoprotéinémie de type II ap rekrite patisipan nan sit atravè Etazini.

Vil ki gen plis etid

Pa eta

Etid ki fèk mete ajou

Tèks ofisyèl etid la (Anglè)

Computerized Decision Support for Identification and Management of Familial Hypercholesterolemia

Ap rekrite
Tout laj · Tout sèks · Mizajou Sep 29, 2026 · NCT06743659

A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease

Ap rekriteFaz 1
Laj 18 a 70 · Tout sèks · Mizajou Sep 2, 2026 · NCT06164730

Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia

Ap rekriteFaz 1
Laj 18 a 70 · Tout sèks · Mizajou Jul 17, 2026 · NCT06451770

Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

Ap rekriteFaz 3
Laj 6 a 11 · Tout sèks · Mizajou May 15, 2026 · NCT06597019

Comparing Direct vs Indirect Methods for Cascade Screening

Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Apr 14, 2026 · NCT05348564

The ORIGIN-FH Study

Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Mar 13, 2026 · NCT07470723

Atlantic Lipid Lowering Treatment Optimization Program

Ap rekrite
Laj 18 a 120 · Tout sèks · Mizajou Aug 3, 2025 · NCT06439654

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.